肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程

2020-04-27 加拿大安大略癌症治疗中心 Curr Oncol . 2020 Apr;27(2):e146-e155.

非小细胞肺癌EGFR突变

2020年4月，加拿大安大略癌症治疗中心(CCO)发布了晚期EGFR突变非小细胞肺癌的系统治疗流程共识。晚期EGFR突变非小细胞肺癌的临床试验近期报道了多种治疗方法，并提出了许多重要的临床问题。本文主

中文标题：

2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程

英文标题：

Canadian Consensus: A New Systemic Treatment Algorithm for Advanced EGFR- Mutated Non-Small-Cell Lung Cancer

发布机构：

加拿大安大略癌症治疗中心

发布日期：

2020-04-27

简要介绍：

2020年4月，加拿大安大略癌症治疗中心(CCO)发布了晚期EGFR突变非小细胞肺癌的系统治疗流程共识。晚期EGFR突变非小细胞肺癌的临床试验近期报道了多种治疗方法，并提出了许多重要的临床问题。本文主要诊断这些问题提出指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ff4161c001931211, title=2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程, enTitle=Canadian Consensus: A New Systemic Treatment Algorithm for Advanced EGFR- Mutated Non-Small-Cell Lung Cancer, guiderFrom=Curr Oncol . 2020 Apr;27(2):e146-e155., authorId=0, author=, summary=2020年4月，加拿大安大略癌症治疗中心(CCO)发布了晚期EGFR突变非小细胞肺癌的系统治疗流程共识。晚期EGFR突变非小细胞肺癌的临床试验近期报道了多种治疗方法，并提出了许多重要的临床问题。本文主, cover=https://img.medsci.cn/202074/1593797531133_2020535.jpg, journalId=0, articlesId=null, associationId=13, associationName=加拿大安大略癌症治疗中心, associationIntro=加拿大安大略癌症治疗中心（CCO，Cancer Care Ontario）是致力于不断改善癌症服务的省级机构，同时为政府的癌症顾问，主要任务包括指导和监督医院和其他组织提供高质量及时的癌症服务；执行省级的癌症预防和筛查方案；与专业人员和组织一起制定和实施质量改进和标准；推进癌症临床实践的改进和创新等等。, copyright=0, guiderPublishedTime=Mon Apr 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年4月，加拿大安大略癌症治疗中心(CCO)发布了晚期EGFR突变非小细胞肺癌的系统治疗流程共识。晚期EGFR突变非小细胞肺癌的临床试验近期报道了多种治疗方法，并提出了许多重要的临床问题。本文主要诊断这些问题提出指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌), TagDto(tagId=1161, tagName=EGFR突变)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1161, guiderKeyword=EGFR突变, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3713, appHits=276, showAppHits=0, pcHits=668, showPcHits=3437, likes=9, shares=52, comments=43, approvalStatus=1, publishedTime=Sat Jul 04 01:32:15 CST 2020, publishedTimeString=2020-04-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 04 01:32:14 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 20:29:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程.pdf)])
2020 CCO加拿大共识：晚期EGFR突变非小细胞肺癌的系统治疗流程.pdf
下载请点击：
评论区 (40)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082404, encodeId=ee2c10824047a, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:51:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899217, encodeId=c02789921eca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Sat Nov 14 23:14:25 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883796, encodeId=a6b6883e965b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36231689668, createdName=cmptmp, createdTime=Wed Sep 09 08:41:30 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806214, encodeId=9f15806214fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Wed Aug 05 02:39:49 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806004, encodeId=7214806004a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Tue Aug 04 04:15:53 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082404, encodeId=ee2c10824047a, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:51:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899217, encodeId=c02789921eca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Sat Nov 14 23:14:25 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883796, encodeId=a6b6883e965b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36231689668, createdName=cmptmp, createdTime=Wed Sep 09 08:41:30 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806214, encodeId=9f15806214fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Wed Aug 05 02:39:49 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806004, encodeId=7214806004a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Tue Aug 04 04:15:53 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-11-14 1361fc5d0em

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082404, encodeId=ee2c10824047a, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:51:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899217, encodeId=c02789921eca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Sat Nov 14 23:14:25 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883796, encodeId=a6b6883e965b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36231689668, createdName=cmptmp, createdTime=Wed Sep 09 08:41:30 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806214, encodeId=9f15806214fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Wed Aug 05 02:39:49 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806004, encodeId=7214806004a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Tue Aug 04 04:15:53 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-09-09 cmptmp

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082404, encodeId=ee2c10824047a, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:51:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899217, encodeId=c02789921eca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Sat Nov 14 23:14:25 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883796, encodeId=a6b6883e965b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36231689668, createdName=cmptmp, createdTime=Wed Sep 09 08:41:30 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806214, encodeId=9f15806214fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Wed Aug 05 02:39:49 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806004, encodeId=7214806004a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Tue Aug 04 04:15:53 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-08-05 sunlong28

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082404, encodeId=ee2c10824047a, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:51:30 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899217, encodeId=c02789921eca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Sat Nov 14 23:14:25 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883796, encodeId=a6b6883e965b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36231689668, createdName=cmptmp, createdTime=Wed Sep 09 08:41:30 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806214, encodeId=9f15806214fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Wed Aug 05 02:39:49 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806004, encodeId=7214806004a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/26/5e1df344d663496bdfd43c465d409e2c.jpg, createdBy=bce679058, createdName=sunlong28, createdTime=Tue Aug 04 04:15:53 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-08-04 sunlong28

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 ATORG专家共识声明：优化Ⅲ期非小细胞肺癌的管理

国外肿瘤科相关专家小组（统称） · 2020-03-15

2019 加拿大共识：渐进性，假进行性和寡转移性非小细胞肺癌

国外肿瘤科相关专家小组（统称） · 2019-02-01

美国国家综合癌症网络非小细胞肺癌指南2019 V1 版更新要点解读

暂未更新 · 2019-01-20